These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22866441)

  • 1. Ammonia abolishers: antibiotics for hepatic encephalopathy.
    Felicilda-Reynaldo RF
    Medsurg Nurs; 2012; 21(3):173-5; quiz 176. PubMed ID: 22866441
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifaximin (Xifaxan 550) for hepatic encephalopathy.
    Med Lett Drugs Ther; 2010 Nov; 52(1350):87. PubMed ID: 21045761
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of Hepatic Encephalopathy: A Primer.
    Jawaro T; Yang A; Dixit D; Bridgeman MB
    Ann Pharmacother; 2016 Jul; 50(7):569-77. PubMed ID: 27126547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update on the management of hepatic encephalopathy].
    García Martínez R; Córdoba Cardona J
    Rev Esp Enferm Dig; 2008 Oct; 100(10):637-44. PubMed ID: 19119790
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial.
    Miglio F; Valpiani D; Rossellini SR; Ferrieri A
    Curr Med Res Opin; 1997; 13(10):593-601. PubMed ID: 9327194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.
    Pedretti G; Calzetti C; Missale G; Fiaccadori F
    Ital J Gastroenterol; 1991 May; 23(4):175-8. PubMed ID: 1751811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.
    Zhu GQ; Shi KQ; Huang S; Wang LR; Lin YQ; Huang GQ; Chen YP; Braddock M; Zheng MH
    Aliment Pharmacol Ther; 2015 Apr; 41(7):624-35. PubMed ID: 25684317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcoholic hepatitis.
    Mohammed F
    N Engl J Med; 2009 Oct; 361(15):1512; author reply 1512-3. PubMed ID: 19812414
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of hepatic encephalopathy with non-absorbable antibiotics.
    Festi D; Mazzella G; Parini P; Ronchi M; Cipolla A; Orsini M; Sangermano A; Bazzoli F; Aldini R; Roda E
    Ital J Gastroenterol; 1992; 24(9 Suppl 2):14-6. PubMed ID: 1486194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifaximin: a nonsystemic antibiotic for hepatic encephalopathy.
    Welliver M
    Gastroenterol Nurs; 2013; 36(2):140-2. PubMed ID: 23549218
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifaximin may have a dramatic effect on hepatic encephalopathy.
    Lamb C; Reddy AV
    Clin Med (Lond); 2012 Oct; 12(5):489-90. PubMed ID: 23101155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifaximine versus neomycin in the treatment of portosystemic encephalopathy.
    Di Piazza S; Gabriella Filippazzo M; Valenza LM; Morello S; Pastore L; Conti A; Cottone S; Pagliaro L
    Ital J Gastroenterol; 1991; 23(7):403-7. PubMed ID: 1742538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficiency of otoph and polydex ear drops in otitis treatment].
    Luchikhin LA; Magomedov MM; Gorbacheva VA
    Vestn Otorinolaringol; 1999; (4):32-4. PubMed ID: 10453233
    [No Abstract]   [Full Text] [Related]  

  • 15. A non-absorbable rifamycin for treatment of hepatic encephalopathy.
    Testa R; Eftimiadi C; Sukkar GS; De Leo C; Rovida S; Schito GC; Celle G
    Drugs Exp Clin Res; 1985; 11(6):387-92. PubMed ID: 3836135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and management of acute and chronic hepatic encephalopathy.
    Jacobson S; Bell B
    Med Clin North Am; 1973 Nov; 57(6):1569-77. PubMed ID: 4583596
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy.
    Kok B; Foxton MR; Clough C; Shawcross DL
    Hepatology; 2013 Oct; 58(4):1516-7. PubMed ID: 23471844
    [No Abstract]   [Full Text] [Related]  

  • 18. Review article: the current pharmacological therapies for hepatic encephalopathy.
    Bass NM
    Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():23-31. PubMed ID: 17295849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
    Leonhardt H; Sanhueza P
    Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of hyperammonemia in liver failure.
    Jover-Cobos M; Khetan V; Jalan R
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):105-10. PubMed ID: 24281376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.